Gilead Sciences Inc (NASDAQ:GILD)

Wednesday’s Trading Day
93.79 +0.80 / +0.86%
Data as of Jul 30
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
92.65 -1.14 / -1.22%
 
Volume: 1.5K
Biotech Stock Roundup: Gilead's Sovaldi & Biogen's Tecfidera Impressive Run Continues...
Jul 30 / Zacks.com
Jim Cramer's Mad Dash: Gilead Sciences Still Has Upside
Jul 24 / TheStreet.com
Why Humana (HUM) Stock Is Declining Today
Jul 30 / TheStreet.com
Stock Market News for July 24, 2014 - Market News
Jul 24 / Zacks.com
Bizarro World Continues
Jul 30 / TheStreet.com
Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog
Jul 24 / Zacks.com
Jim Cramer's Mad Dash: Good News for Regeneron
Jul 30 / TheStreet.com
Frontrunning: July 24
Jul 24 / Investing Channel
Stock Market News for July 30, 2014 - Market News
Jul 30 / Zacks.com
Today's Momo Momentum Stock To Watch: Gilead (GILD)
Jul 24 / TheStreet.com
3 Stocks Boosting The Drugs Industry Higher
Jul 29 / TheStreet.com
Gilead Beats Q2 Views On Revenue Growth Lead By Sovaldi Drug
Jul 24 / Benzinga
Gilead Sciences, Inc. (GILD): The Bullish Case For The Stock
Jul 29 / Investing Channel
Jim Cramer's Top Stock Picks: PEP CELG GILD REGN BIIB CMG
Jul 24 / TheStreet.com
Gilead's Oncology Drug Recommended for Approval in the EU - Analyst Blog
Jul 28 / Zacks.com
Gilead Stock's Great Expectations and Giant Opportunity
Jul 23 / MotleyFool.com
Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
Jul 28 / Zacks.com
Gilead Sciences Crushes Second-Quarter Earnings
Jul 23 / MotleyFool.com
Why Ibm Bullish On Gilead Sciences, Inc. (GILD)
Jul 28 / Investing Channel
Is Gilead About to Crush Pharmacyclics Stock?
Jul 23 / MotleyFool.com
Amgen Shares Have the Right Prescription for Long-Term Growth
Jul 28 / TheStreet.com
Why Do We Watch the Dow Jones So Closely When its Makeup Makes No Sense?
Jul 23 / MotleyFool.com
Why Gilead Sciences (GILD) Stock Is Up Today
Jul 28 / TheStreet.com
Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst...
Jul 23 / Zacks.com
#PreMarket Primer: Monday, July 28: Tension Between U.S. And Israel On The Rise
Jul 28 / Benzinga
3 Stocks to Get on Your Watchlist
Jul 23 / MotleyFool.com
Time may be up for tech 'game changers'
Jul 28 / FT.com
3 Things You Need to Watch on Gilead Sciences Inc. Earnings Call
Jul 22 / MotleyFool.com
I'm Less Skeptical After These Results
Jul 25 / TheStreet.com
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Jul 22 / MotleyFool.com
Why Gilead Stock's Newest Drug Approval Isn't a Gamechanger
Jul 25 / MotleyFool.com
Will Gilead (GILD) Earnings Disappoint in Q2 as Costs Rise? - Analyst Blog
Jul 22 / Zacks.com
Why Gilead Sciences, inc. Stock Was Flat Today
Jul 24 / MotleyFool.com
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
Jul 22 / MotleyFool.com
Biotech Stocks With Unique Diagnostic and Therapeutic Technologies
Jul 24 / Investing Channel
Gilead Earnings: Can Sovaldi Reach $3 Billion?
Jul 21 / MotleyFool.com
3 Crucial Quotes From Gilead Sciences Stock
Jul 24 / MotleyFool.com
Yellen Hates Biotech Stocks! Should You?
Jul 21 / MotleyFool.com
Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
Jul 24 / Zacks.com
Gilead Sciences Stock's Huge Hidden Opportunity
Jul 18 / MotleyFool.com
What Gilead Stock's Latest Blockbuster Approval Means for Investors
Jul 24 / MotleyFool.com
Do Johnson & Johnson's Results Suggest a Pop or Drop for Gilead Sciences?
Jul 17 / MotleyFool.com
Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
Jul 24 / Zacks.com
Americans stock up on Tylenol, baby products
Jul 15 / CNNMoney.com
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences...
Jul 24 / MotleyFool.com
Beware of social media, biotech stocks
Jul 15 / CNNMoney.com
3 Stocks Improving Performance Of The Health Care Sector
Jul 24 / TheStreet.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.